These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 10918513)

  • 21. Transplantation: toxicokinetics and mechanisms of toxicity of cyclosporine and macrolides.
    Serkova N; Christians U
    Curr Opin Investig Drugs; 2003 Nov; 4(11):1287-96. PubMed ID: 14758767
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapamycin: a novel immunosuppressive macrolide.
    Sehgal SN; Molnar-Kimber K; Ocain TD; Weichman BM
    Med Res Rev; 1994 Jan; 14(1):1-22. PubMed ID: 8309312
    [No Abstract]   [Full Text] [Related]  

  • 23. The effect of rapamycin on orthotopic small bowel transplantation in the rat.
    Chen H; Wu J; Xu D; Aboujaoude M; Stepkowski S; Kahan B; Daloze P
    Transplant Proc; 1992 Jun; 24(3):1157-8. PubMed ID: 1604567
    [No Abstract]   [Full Text] [Related]  

  • 24. Impact of immunosuppressants on the therapeutic efficacy of in vitro-expanded CD4+CD25+Foxp3+ regulatory T cells in allotransplantation.
    Lim DG; Koo SK; Park YH; Kim Y; Kim HM; Park CS; Kim SC; Han DJ
    Transplantation; 2010 Apr; 89(8):928-36. PubMed ID: 20305583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Donor pretreatment with rapamycin delays rejection following intestinal allotransplantation.
    He G; Zhong R; Zhang Z; Garcia B; Black R; Duff J; Grant D
    Transplant Proc; 1992 Jun; 24(3):1178. PubMed ID: 1604577
    [No Abstract]   [Full Text] [Related]  

  • 26. Prolonged sirolimus administration after allogeneic hematopoietic cell transplantation is associated with decreased risk for moderate-severe chronic graft-versus-host disease.
    Pidala J; Kim J; Alsina M; Ayala E; Betts BC; Fernandez HF; Field T; Jim H; Kharfan-Dabaja MA; Locke FL; Mishra A; Nishihori T; Ochoa-Bayona L; Perez L; Riches M; Anasetti C
    Haematologica; 2015 Jul; 100(7):970-7. PubMed ID: 25840599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Model of acute graft-vs-host-disease in adult (SHR x BN.lx)F1 rats and its inhibition by adenine analog.
    Kren V; Otová B; Elleder D; Elleder M; Panczak A; Sladká M
    Transplant Proc; 1993 Oct; 25(5):2822-3. PubMed ID: 8212248
    [No Abstract]   [Full Text] [Related]  

  • 28. Tacrolimus (FK506) and methotrexate regimens to prevent graft-versus-host disease after unrelated dog leukocyte antigen (DLA) nonidentical marrow transplantation.
    Yu C; Storb R; Deeg HJ; Graham TC; Scheuning FG; Huss R; Seidel K; Fitzsimmons WE
    Bone Marrow Transplant; 1996 Apr; 17(4):649-53. PubMed ID: 8722370
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sirolimus: continuing the evolution of transplant immunosuppression.
    Ingle GR; Sievers TM; Holt CD
    Ann Pharmacother; 2000 Sep; 34(9):1044-55. PubMed ID: 10981252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Macrolide immunosuppressants.
    Mrowietz U
    Eur J Dermatol; 1999; 9(5):346-51. PubMed ID: 10417434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sirolimus-containing graft-versus-host disease prophylaxis in patients with lymphoma.
    Mehta J
    J Clin Oncol; 2009 Oct; 27(28):e138; author reply e139-40. PubMed ID: 19720890
    [No Abstract]   [Full Text] [Related]  

  • 32. Rapamycin (sirolimus) inhibits heart cell growth in vitro.
    Burton PB; Yacoub MH; Barton PJ
    Pediatr Cardiol; 1998; 19(6):468-70. PubMed ID: 9770573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Possible correlation of sirolimus plasma concentration with sinusoidal obstructive syndrome of the liver in patients undergoing myeloablative allogeneic hematopoietic cell transplantation.
    Kiel PJ; Vargo CA; Patel GP; Rosenbeck LL; Srivastava S
    Pharmacotherapy; 2012 May; 32(5):441-5. PubMed ID: 22499411
    [TBL] [Abstract][Full Text] [Related]  

  • 34. For organ transplant recipients, cancer threatens long-term survival.
    Ross K
    J Natl Cancer Inst; 2007 Mar; 99(6):421-2. PubMed ID: 17374827
    [No Abstract]   [Full Text] [Related]  

  • 35. Sirolimus as part of immunosuppressive therapy for refractory chronic graft-versus-host disease.
    Jurado M; Vallejo C; Pérez-Simón JA; Brunet S; Ferra C; Balsalobre P; Pérez-Oteyza J; Espigado I; Romero A; Caballero D; Sierra J; Ribera JM; Díez JL
    Biol Blood Marrow Transplant; 2007 Jun; 13(6):701-6. PubMed ID: 17531780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological profile of A85 4777, a novel antiinflammatory agent with nonclassical immunosuppressive properties.
    Bartlett RR; Schleyerbach R; Schorlemmer KU; Wolf E
    Transplant Proc; 1990 Aug; 22(4):1666-70. PubMed ID: 2389430
    [No Abstract]   [Full Text] [Related]  

  • 37. Role of endothelin-1 and nitric oxide bioavailability in transplant-related vascular injury: comparative effects of rapamycin and cyclosporine.
    Ramzy D; Rao V; Tumiati LC; Xu N; Miriuka S; Delgado D; Ross HJ
    Circulation; 2006 Jul; 114(1 Suppl):I214-9. PubMed ID: 16820575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition by deoxyspergualin of allo-reactive cytotoxic activity in mouse graft-versus-host disease.
    Nemoto K; Hayashi M; Abe F; Takita T; Takeuchi T
    Transplant Proc; 1989 Feb; 21(1 Pt 3):3028-30. PubMed ID: 2650418
    [No Abstract]   [Full Text] [Related]  

  • 39. Evaluation of individual and combined neurotoxicity of the immunosuppressants cyclosporine and sirolimus by in vitro multinuclear NMR spectroscopy.
    Serkova N; Litt L; James TL; Sadée W; Leibfritz D; Benet LZ; Christians U
    J Pharmacol Exp Ther; 1999 May; 289(2):800-6. PubMed ID: 10215655
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The immunosuppressive macrolide RAD inhibits growth of human Epstein-Barr virus-transformed B lymphocytes in vitro and in vivo: A potential approach to prevention and treatment of posttransplant lymphoproliferative disorders.
    Majewski M; Korecka M; Kossev P; Li S; Goldman J; Moore J; Silberstein LE; Nowell PC; Schuler W; Shaw LM; Wasik MA
    Proc Natl Acad Sci U S A; 2000 Apr; 97(8):4285-90. PubMed ID: 10759564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.